Abstract
Approximately 80% of rare diseases have a genetic cause, and an accurate genetic diagnosis is necessary for disease management, prognosis prediction, and genetic counseling. Whole-exome sequencing (WES) is a cost-effective approach for exploring the genetic cause, but several cases often remain undiagnosed. We combined whole genome sequencing (WGS) and RNA sequencing (RNA-seq) to identify the pathogenic variants in an unsolved case using WES. RNA-seq revealed aberrant exon 4 and exon 6 splicing of ITPA. WGS showed a previously unreported splicing donor variant, c.263+1G>A, and a novel heterozygous deletion, including exon 6. Detailed examination of the breakpoint indicated the deletion caused by recombination between Alu elements in different introns. The proband was found to have developmental and epileptic encephalopathies caused by variants in the ITPA gene. The combination of WGS and RNA-seq may be effective in diagnosing conditions in proband who could not be diagnosed using WES.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
Raw data are available from the corresponding author upon reasonable request. Some genomic information that could be used to identify individuals cannot be shared due to ethical constraints.
References
Clark MM, Stark Z, Farnaes L, Tan TY, White SM, Dimmock D, et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. npj Genom Med. 2018;3:1–10.
Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, Iuso A, et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun. 2017;8:1–11.
Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR, et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing Genotype-Tissue Expression Consortium. Sci Transl Med. 2016;5209:1–12.
Brechtmann F, Mertes C, Matusevičiūtė A, Yépez VA, Avsec Ž, Herzog M, et al. OUTRIDER: a statistical method for detecting aberrantly expressed genes in RNA sequencing data. Am J Hum Genet. 2018;103:907–17.
Kevelam SH, Bierau J, Salvarinova R, Agrawal S, Honzik T, Visser D, et al. Recessive ITPA mutations cause an early infantile encephalopathy. Ann Neurol. 2015;78:649–58.
Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC, et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet. 2002;111:360–7.
Scala M, Wortmann SB, Kaya N, Stellingwerff MD, Pistorio A, Glamuzina E, et al. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat. 2022;43:403–19.
Handley MT, Reddy K, Wills J, Rosser E, Kamath A, Halachev M, et al. ITPase deficiency causes a martsolf-like syndrome with a lethal infantile dilated cardiomyopathy. PLoS Genet. 2019;15:1–23.
Behmanesh M, Sakumi K, Abolhassani N, Toyokuni S, Oka S, Ohnishi YN, et al. ITPase-deficient mice show growth retardation and die before weaning. Cell Death Differ. 2009;16:1315–22.
Kim S, Cho C-S, Han K, Lee J. Structural variation of Alu element and human disease. Genom Inf. 2016;14:70–7.
Pascarella G, Hon CC, Hashimoto K, Busch A, Luginbühl J, Parr C, et al. Recombination of repeat elements generates somatic complexity in human genomes. Cell. 2022;185:3025–3040.e6.
Kishita Y, Shimura M, Kohda M, Fushimi T, Nitta KR, Yatsuka Y, et al. Genome sequencing and RNA-seq analyses of mitochondrial complex I deficiency revealed Alu insertion-mediated deletion in NDUFV2. Hum Mutat. 2021;42:1422–8.
Yépez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, et al. Clinical implementation of RNA sequencing for Mendelian disease diagnostics. Genome Med. 2022;14:1–26.
Acknowledgements
We thank the family for their participation in the study.
Funding
This work was supported by a grant for the Practical Research Project for Rare/Intractable Diseases from AMED to KM, YO, and AO (Fund ID: JP21ek010946, 22ek0109485, JP22ek0109468, JP19ek0109273), Program for Promoting Platform of Genomics based Drug Discovery to YO (Fund ID: JP22kk0305015) and JSPS KAKENHI JP19H03624 to YO.
Author information
Authors and Affiliations
Contributions
NO and YK wrote the manuscript. NO and YK performed the experiments. NO, YK, KRN, TF and YY analyzed the data. MN, HS, AT, EK, YS, KI and KM acquired clinical information. YK, AO, KM, and YO supervised the study. All authors discussed the results and commented on the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The study was approved by the regional Ethics Committees of Juntendo University, Saitama Medical University, Chiba Children’s Hospital, and Kindai University. Written informed consent was obtained from the parents. All methods were performed by relevant guidelines and regulations.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Omichi, N., Kishita, Y., Nakama, M. et al. Novel ITPA variants identified by whole genome sequencing and RNA sequencing. J Hum Genet 68, 649–652 (2023). https://doi.org/10.1038/s10038-023-01156-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-023-01156-y